Osteoarthritis less likely to occur in ticagrelor- vs clopidogrel-treated patients
Ticagrelor appears to reduce the risk of developing osteoarthritis (OA) more than clopidogrel, with the OA-free survival advantage persisting through 5 years of follow-up, according to a study.
